Sanaregen Vision Therapeutics invites investors to reserve shares as it prepares for an equity crowdfunding campaign to advance retinal disease treatments.

Investors who braved multiple steep drops in the market this year and held on have been rewarded, with the S&P 500 back at ...

NuScale Power is trying to disrupt the energy sector with small modular reactors. NuScale Power stock doesn't generate much ...

Given all that has transpired in the first half of this year, many investors might be surprised to look at their portfolios and find some good news. US stocks are up about 5% so far in 2025, and a ...

Limited has secured a major interior and fit-out contract worth Rs 57 crore from a leading multinational corporation. This ...

Nasdaq, Inc. (Nasdaq: NDAQ) today announced the Nasdaq Closing Cross had a record day as it was used to rebalance Nasdaq-listed securities in the entire family ...

Serious about understanding the stock market? Whether you're investing for yourself or eyeing a finance career, knowing how ...

The company, which filed draft IPO papers this month for a ₹1,700-crore offering, has grown impressively over the past few ...

Dryden Pence, Pence Capital Management CIO, in a recent program on CNBC explained why NVIDIA Corp (NASDAQ:NVDA) remains his ...

Shares in electronic design automation (EDA) company Synopsys ( SNPS 2.22%) were up by more than 5% at 10 a.m. ET today. The ...

A Bank of America analyst sees a stock bubble forming in the second half of 2025, fueled by the prospect of lower interest ...